Skip to content

Functional Exercise Training in Cerebral Palsy: Follow Up

Functional Exercise Training With Adolescents and Young Adults With Cerebral Palsy: Follow Up Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05859360
Acronym
FITCP
Enrollment
27
Registered
2023-05-16
Start date
2023-06-01
Completion date
2024-03-26
Last updated
2024-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Keywords

functional training, strength, cardiovascular health, cerebral palsy

Brief summary

The goal of this cross-sectional study is to compare able-bodied peers to adolescents and young adults with cerebral palsy (CP) who have been regularly performing high-intensity functional training for almost two years. The main research question is: is structured, long-term exercise training able to compensate strength and cardiovascular deficits in adolescents with CP compared to able-bodied peers?

Detailed description

The pilot study investigating the effects of a functional exercise training in adolescents and young adults with cerebral palsy (CP) showed increases in strength, power, daily function as well as cardiovascular health. In order to establish the origin of the improvements and its broader effects, we wish to conduct follow-up measurements to the pilot study. These follow-up measurements would establish whether the positive changes in physical performance are due to neural or muscular changes (or both), and shed more light on how therapy should be performed and prescribed in adolescents with CP. Additionally, we wish to measure their aerobic capacity as well as examine their microvascular health. For this cross-sectional analysis, the participants of the CP-FIT Pilot Study who continued to train on a regular basis will be compared to age-matched peers in order to establish whether their strength and fitness deficits compared to peers can be compensated through structured and progressive functional exercise training.

Interventions

OTHERPhysical performance and cardiovascular health measures

* Retinal vessel analysis * Muscle ultrasound * Knee extension * Voluntary activation * spiroergometry

Sponsors

University of Basel
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
14 Years to 27 Years
Healthy volunteers
Yes

Inclusion criteria

CP Individuals: * Diagnosis of CP. * Between 14 and 26 years of age. * Gross Motor Functional Classification System (GMFCS): I-II. * Cognitive abilities must include: Ability to verbally or non-verbally communicate pain or discomfort; Ability to attend testing and; ability to understand and follow instructions. All included participants are capable of making decisions on their own and no not show any signs of mental or cognitive limitations. Healthy peers: \- Between 14 and 26 years of age.

Exclusion criteria

CP Individuals: * Any surgery or botulinum toxin treatment within 6 months prior to the measurements or scheduled during study period. Other medications can be continued as prescribed by the participants' physician. * Known cardiovascular or pulmonary diseases that have not received medical clearance to participate in physical exercise. * Uncontrolled seizures or epilepsy. * Inability to conform to the above mentioned cognitive and physical abilities. Healthy peers: * Diagnosis of congenital heart defects, pulmonary diseases or any neuromuscular disorders or diseases. * Diagnosis of any acute diseases.

Design outcomes

Primary

MeasureTime frameDescription
Maximum knee extension force20 minutesMaximum force of knee extension in relation to body weight

Secondary

MeasureTime frameDescription
Microvascular health5 minutesStatic retinal vessel analysis
Voluntary activation15 minutesMaximum force able to voluntarily activate
Spiroergometry20 minutesCardiopulmonary test on bicycle ergometer
Muscle architecture10 minutesUltrasound of defined muscle groups

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 3, 2026